Melanoma-associated cell-surface antigens (MACSA)

Melanoma-associated cell-surface antigens (MACSA) comprise a heterogeneous group of proteins, glycoproteins, and glycolipids that are preferentially or overexpressed on the plasma membrane of melanoma cells. This category includes prominent therapeutic targets such as Chondroitin Sulfate Proteoglycan 4 (CSPG4, also known as High Molecular Weight Melanoma-Associated Antigen or HMW-MAA), Melanoma Cell Adhesion Molecule (MCAM/CD146), Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB), and gangliosides like GD2 and GD3. Biologically, these molecules are involved in critical processes such as cell-matrix adhesion, migration, invasion, and the activation of intracellular signaling pathways (e.g., MAPK and PI3K/Akt) that drive tumor progression and survival. Due to their high density on the surface of malignant cells and relatively restricted expression in normal tissues, MACSAs serve as primary targets for advanced therapeutic modalities including monoclonal antibodies, antibody-drug conjugates (ADCs), and chimeric antigen receptor (CAR) T-cell therapies. For example, glembatumumab vedotin is an ADC designed to target GPNMB, while dinutuximab is an FDA-approved antibody targeting GD2. While these antigens offer significant potential for precision oncology, challenges such as antigen heterogeneity within tumors and the risk of on-target off-tumor toxicity to healthy tissues expressing low levels of the antigens remain key considerations in drug development.

Other names

Melanoma-associated antigensMAAMelanoma surface antigensTumor-associated antigens of melanoma

Drugs targeting these antigens typically function as antibody-drug conjugates (ADCs) to deliver cytotoxins, or as monoclonal antibodies that induce antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). Some therapies, such as CAR-T cells, utilize these antigens to direct T-cell mediated killing of tumor cells, while others may inhibit the biological signaling or adhesion functions of the target molecule to suppress tumor growth and metastasis.